Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Ridker, Paul M.; MacFadyen, Jean G.; Thuren, Tom

Results

eNauka > Rezultati > Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Naziv:	Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Autori:	Ridker, Paul M.; MacFadyen, Jean G.; Thuren, Tom
Godina:	2017
Publikacija:	Lancet
ISSN:	0140-6736 Lancet Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 390 br. 10105 str. 1833-1842
URI:	https://enauka.gov.rs/handle/123456789/446728
Izvor metapodataka:	Migrirano iz RIS podataka
M-kategorija:	21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.